VG Life Sciences, Inc. Announces Filing of Form 10 with the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
VG Life Sciences, Inc. Announces Filing of Form 10 with the SEC.

SANTA BARBARA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, Inc. (VGLS) is a publically traded biotechnology company focused on developing treatments for patients suffering from autoimmune and infectious diseases.

VG Life Sciences is pleased to announce the filing of Form 10 with the Securities & Exchange Commission on June 19, 2014. Form 10 filings provide comprehensive information about the capital structure, financial condition, history and governance of the company. Once the Form 10 statement is effective VGLS will file annual reports on form 10K, quarterly reports on 10Q and periodic reports on form 8K.

"This is a significant milestone that will provide transparency with the investment community," said John Tynan, President and CEO.

In May the company completed prior year audits. When the Form 10 is effective, the company plans to move from the OTC Pink market to the OTCQB.

"We believe this will provide our shareholders with a more robust trading platform and thus increased liquidity," said Tynan. "We continue to complete key milestones as announced in July related to new capital investment, moving our science forward into pre-clinical safety trials, protecting our intellectual property, completing our audit and now filing the Form 10."

The Company also seeks to clarify a reference to the accumulated deficit and loss carry forward from our May 13, 2013 Letter to Shareholders. VG Life Sciences, Inc.'s loss carry forward is $44,000,000.

You can find a copy of the filing by clicking here .

About VG Life Sciences Inc.

Santa Barbara, California-based VG Life Sciences, Inc., formerly known as Viral Genetics, is a biotechnology company focused on discovering and developing drug therapies for cancer, infectious disease, and inflammatory, autoimmune disorders. VGLS controls over 45 US and international patents and pending patents protecting its exclusive biotech platform technologies. For more information and upcoming events, visit www.vglifesciences.com or find VG Life Sciences, Inc. on Facebook , Twitter , and LinkedIn .

Safe Harbor Statement and Forward-Looking Statements

This news release may contain forward-looking statements that involve risks and uncertainties associated with financial projections, milestone timelines, clinical development, regulatory approvals and other risks described by VG Life Sciences from time to time in its periodic reports. None of VG Life Sciences' drug compounds are approved by the US FDA or by any comparable regulatory agencies elsewhere in the world. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by VG Life Sciences Inc. or any other person that the objectives and plans of VG Life Sciences will be achieved.

Contact:

Allison Trabucco, Corporate Communications
VG Life Sciences, Inc.
Phone: (805) 879-9000
Email: atrabucco@vglifesciences.com

Allison Trabucco, Corporate Communications VG Life Sciences, Inc. Phone: (805) 879-9000 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 201

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 192

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 249

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 298

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 193

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading

Top 5 Most Recently Viewed Articles

TransAlta Announces Q3 2025 Conference Call Details

Updated Category News Views 158

TransAlta's Upcoming Third Quarter Results Conference Call TransAlta Corporation is gearing up for an important announcement as it prepares to release its third quarter 2025 financial results. This eagerly awaited information will be made available before the markets open on a Thursday in early November. Conference Call Schedule On the morning of the announcement, at 9:00...

Continue Reading
Soma Gold Corp. Shares AGM Results and Stock Options Grant

Updated Category News Views 128

Insights from Soma Gold Corp.'s Recent Annual General Meeting Soma Gold Corp. (TSXV: SOMA) recently conducted its Annual General Meeting (AGM), where key decisions were made that will shape the company's future. With strong support from its shareholders, the AGM served as a platform for transparency and engagement, which are essential aspects of sustainable business...

Continue Reading
Pinnacle Financial Partners Enhances Growth Outlook Following Q3 Success

Updated Category News Views 102

Pinnacle Financial Partners Reports Stellar Q3 Performance Pinnacle Financial Partners (NASDAQ: PNFP) has shared impressive third-quarter results, highlighting significant advancements in loans, deposits, and earning assets. The company also took the opportunity to recalibrate its 2024 financial expectations while reaffirming its commitment to ongoing growth. Key...

Continue Reading
METLEN Posts Record 9-Month Revenue in 2026

Updated Category News Views 264

Record Revenue Achievement Oh boy, METLEN just broke the bank with its nine-month trading update for 2026, hitting €6.2 billion in revenue. It's the highest they've ever seen for this period. A 21% jump from the previous €5.1 billion in 9M2025—now that's saying something in these unpredictable markets. Drilling down, the company’s business units showed they can...

Continue Reading
InnoPhase IoT Launches Talaria 6 SoCs Boosting Connectivity & Security

Updated Category News Views 677

InnoPhase IoT's Revolutionary Talaria 6 Series of SoCs InnoPhase IoT, Inc., a leader in wireless semiconductor platforms, has recently unveiled the impressive Talaria 6 Family of System-on-Chips (SoCs). These advanced offerings come equipped with multi-protocol wireless connectivity, such as Wi-Fi 6 and Bluetooth 6.0, crafted to meet the contemporary demands of the...

Continue Reading